Absorption |
Blood-Brain Barrier | BBB+ | 0.9723 |
Human Intestinal Absorption | HIA+ | 0.9947 |
Caco-2 Permeability | Caco2+ | 0.7133 |
P-glycoprotein Substrate | Substrate | 0.8903 |
P-glycoprotein Inhibitor | Inhibitor | 0.8607 |
Non-inhibitor | 0.8035 |
Renal Organic Cation Transporter | Non-inhibitor | 0.6666 |
Distribution |
Subcellular localization | Mitochondria | 0.4036 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8534 |
CYP450 2D6 Substrate | Substrate | 0.5920 |
CYP450 3A4 Substrate | Substrate | 0.7738 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9387 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8994 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.6577 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8891 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7808 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9432 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8988 |
Non-inhibitor | 0.8646 |
AMES Toxicity | Non AMES toxic | 0.7809 |
Carcinogens | Non-carcinogens | 0.9381 |
Fish Toxicity | High FHMT | 0.9850 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9989 |
Honey Bee Toxicity | High HBT | 0.5431 |
Biodegradation | Not ready biodegradable | 0.9884 |
Acute Oral Toxicity | III | 0.5543 |
Carcinogenicity (Three-class) | Non-required | 0.5717 |